Nasdaq Biotechnology Ishares (IBB) 307.79 $IBB Jim

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 307.79 $IBB

Jim Cramer -- Take Cisco Over Juniper and Buy Celgene, Too
at The Street - Wed Oct 07, 10:24AM CDT
Cramer likes Cisco Systems' low valuation and exposure to the cyber security industry. He loves Celgene for its above-average growth and reasonable valuation.
IBB: 307.79 (+5.88), CSCO: 27.54 (+0.31), CELG: 116.98 (+4.79), JNPR: 29.42 (+1.00)

iShares Nasdaq Biotechnology Index Falls 3.60% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Oct 06, 3:44PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.55 to a high of $310.00. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $297.00 on volume of 5.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 307.79 (+5.88)

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Rebound after Yesterday's 3.60% Sell Off
Comtex SmarTrend(R) - Tue Oct 06, 3:44PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $292.55 to a high of $310.00. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $297.00 on volume of 5.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 307.79 (+5.88)

Stocks Close Mixed as Biotech Slumps, Energy Jumps
at The Street - Tue Oct 06, 3:38PM CDT
It's a very different day of trading for the investor favoring energy stocks compared to those hedging their bets on biotech.
BIIB: 279.24 (+3.25), SWKS: 83.61 (+2.90), HAL: 39.86 (+0.82), ILMN: 145.94 (+0.13), XOM: 79.20 (+1.31), IBB: 307.79 (+5.88), COP: 55.27 (+0.13), PMCS: 10.18 (-0.06), TCS: 12.04 (-0.63), LLY: 83.99 (-0.18), BMY: 60.55 (+0.67), ENS: 64.70 (+0.84), PEP: 98.52 (+1.45), AA: 10.94 (-0.04), DD: 55.38 (+0.17), TEVA: 58.55 (+0.58), CVX: 88.12 (+1.13), PTR: 79.48 (+3.96), JCI: 43.86 (+0.80), XLE: 68.09 (+0.85)

Why Biotech Stocks Were Crushed, Again
Brian Feroldi, The Motley Fool - Motley Fool - Tue Oct 06, 3:24PM CDT
What:  It was another tough day to be a biotech investor as the entire sector was once again sold-off hard today. The  iShares Nasdaq Biotechnology ETF  , an exchange traded fund that holds a basket of 144 biotech stocks with market caps over $200...
IBB: 307.79 (+5.88)

DuPont Still has Upside; Investors Seek Value Over Growth
at The Street - Tue Oct 06, 2:44PM CDT
The CNBC 'Fast Money' traders say DuPont still has upside despite Tuesday's 10% rally, while PepsiCo, McDonald's and Yum! Brands could also continue to rally.
SPY: 199.41 (+1.62), DIA: 168.95 (+1.26), MCD: 101.77 (-0.13), DD: 55.38 (+0.17), IBB: 307.79 (+5.88), BWLD: 194.16 (+3.32), PEP: 98.52 (+1.45), TXRH: 38.37 (+0.17), YUM: 67.71 (-15.71), XLE: 68.09 (+0.85)

Dow Edges Up as Oil Closes at Five-Week High
at The Street - Tue Oct 06, 2:16PM CDT
Stocks are mixed on Tuesday afternoon as energy pushes the Dow Jones Industrial Average higher while a biotech selloff weighs on the Nasdaq.
BUD: 110.96 (+1.36), BIIB: 279.24 (+3.25), SWKS: 83.61 (+2.90), HAL: 39.86 (+0.82), TAP: 82.21 (+1.22), ILMN: 145.94 (+0.13), IBB: 307.79 (+5.88), XOM: 79.20 (+1.31), COP: 55.27 (+0.13), PMCS: 10.18 (-0.06), TCS: 12.04 (-0.63), LLY: 83.99 (-0.18), BMY: 60.55 (+0.67), PEP: 98.52 (+1.45), AA: 10.94 (-0.04), DD: 55.38 (+0.17), TEVA: 58.55 (+0.58), CVX: 88.12 (+1.13), AAPL: 110.78 (-0.53), PTR: 79.48 (+3.96), XLE: 68.09 (+0.85)

Stocks Move Back Into Red as Biotech Sells Off Again
at The Street - Tue Oct 06, 9:36AM CDT
Stocks move back into the red by mid-morning Tuesday as the biotech sector suffers another selloff.
BUD: 110.96 (+1.36), BIIB: 279.24 (+3.25), SWKS: 83.61 (+2.90), TAP: 82.21 (+1.22), IBB: 307.79 (+5.88), ILMN: 145.94 (+0.13), LLY: 83.99 (-0.18), TCS: 12.04 (-0.63), PMCS: 10.18 (-0.06), BMY: 60.55 (+0.67), PEP: 98.52 (+1.45), AA: 10.94 (-0.04), DD: 55.38 (+0.17), TEVA: 58.55 (+0.58), AAPL: 110.78 (-0.53)

'Fast Money' Recap: Have Markets Risen Too Far Too Fast?
at The Street - Tue Oct 06, 4:00AM CDT
The trading panel discussed Dupont, Norman Peltz and if today's stock market is acting like 2011's.
SPY: 199.41 (+1.62), GILD: 100.27 (+2.73), DD: 55.38 (+0.17), IBB: 307.79 (+5.88), CELG: 116.98 (+4.79)

Stocks Climb in Year's Longest Winning Streak
at The Street - Mon Oct 05, 3:08PM CDT
Wall Street welcomes big gains, and a 2015 winning streak, to kick off the new week.
KMI: 32.14 (+0.36), BIIB: 279.24 (+3.25), GE: 27.77 (+0.48), POT: 22.16 (+0.96), XOM: 79.20 (+1.31), COP: 55.27 (+0.13), IBB: 307.79 (+5.88), LLY: 83.99 (-0.18), BMY: 60.55 (+0.67), APP: 0.11 (unch), RDS.A: 54.97 (+1.50), GOOGL: 670.00 (-1.64), TEVA: 58.55 (+0.58), TWTR: 29.83 (+2.21), CVX: 88.12 (+1.13), XLE: 68.09 (+0.85)

3 Reasons ISIS Pharmaceuticals Is a Buy
Brian Feroldi, The Motley Fool - Motley Fool - Mon Oct 05, 2:43PM CDT
Image source: ISIS Pharmaceuticals. After years of providing investors with market-crushing returns, biotech stocks as a group have taken quite the beat-down recently. After reaching a brief peak in price over the summer months,  iShares Nasdaq...
ISIS: 42.44 (+2.27), IBB: 307.79 (+5.88)

S&P 500 on Track for Longest Winning Streak of 2015
at The Street - Mon Oct 05, 2:15PM CDT
Stocks extend big gains into the final hour of trading Monday, putting the S&P 500 on track for its longest winning streak this year.
KMI: 32.14 (+0.36), BIIB: 279.24 (+3.25), GE: 27.77 (+0.48), POT: 22.16 (+0.96), XOM: 79.20 (+1.31), COP: 55.27 (+0.13), IBB: 307.79 (+5.88), LLY: 83.99 (-0.18), BMY: 60.55 (+0.67), APP: 0.11 (unch), RDS.A: 54.97 (+1.50), GOOGL: 670.00 (-1.64), TEVA: 58.55 (+0.58), TWTR: 29.83 (+2.21), CVX: 88.12 (+1.13), XLE: 68.09 (+0.85)

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 3.42% Yesterday
Comtex SmarTrend(R) - Fri Oct 02, 3:53PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $297.22 to a high of $316.00. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $305.94 on volume of 4.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 307.79 (+5.88)

After Yesterday's Rally of 3.42% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Oct 02, 3:52PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $297.22 to a high of $316.00. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $305.94 on volume of 4.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 307.79 (+5.88)

Stocks Close Higher but Worries About Economy Persist
at The Street - Fri Oct 02, 3:01PM CDT
Stocks manage to reverse an earlier selloff on Friday, but the dismal jobs report leaves many investors uneasy.
MU: 18.62 (+0.40), PRGS: 23.91 (+0.25), PFE: 33.29 (+0.50), XOM: 79.20 (+1.31), IBB: 307.79 (+5.88), BAC: 15.75 (+0.06), LLY: 83.99 (-0.18), BMY: 60.55 (+0.67), SIG: 138.30 (+2.15), CELG: 116.98 (+4.79), RDS.A: 54.97 (+1.50), TOT: 51.24 (+1.37), BP: 35.71 (+1.40), CVX: 88.12 (+1.13), PTR: 79.48 (+3.96), XLE: 68.09 (+0.85)

Stocks Climb as Crude Oil Jumps, Energy Rallies
at The Street - Fri Oct 02, 1:42PM CDT
Stocks pull higher Friday afternoon as the biotech sector stages a minor rally and overshadows a disappointing jobs report earlier in the session.
MU: 18.62 (+0.40), MDLZ: 44.33 (+0.43), PRGS: 23.91 (+0.25), PFE: 33.29 (+0.50), XOM: 79.20 (+1.31), IBB: 307.79 (+5.88), BAC: 15.75 (+0.06), LLY: 83.99 (-0.18), BMY: 60.55 (+0.67), SIG: 138.30 (+2.15), CELG: 116.98 (+4.79), RDS.A: 54.97 (+1.50), TOT: 51.24 (+1.37), BP: 35.71 (+1.40), TMUS: 40.37 (-0.28), CVX: 88.12 (+1.13), PTR: 79.48 (+3.96), XLE: 68.09 (+0.85)

Biotech ETFs Looking Attractive After Sell-Off
Sweta Killa - Zacks Investment Research - Thu Oct 01, 7:55AM CDT
The current slide in biotech sector made the stocks valuation attractive at the current levels.
BBP: 28.55 (+0.45), SBIO: 28.79 (+0.44), XBI: 64.30 (+1.08), IBB: 307.79 (+5.88)

'Fast Money' Recap: Time to Pick Stocks in the Fourth Quarter
at The Street - Thu Oct 01, 4:00AM CDT
The trading panel discussed bank stocks, biotechs and whether Twitter is doing the right thing if it makes Jack Dorsey the CEO.
BIIB: 279.24 (+3.25), GS: 182.23 (+1.91), JPM: 62.13 (+0.08), FB: 92.40 (-0.40), C: 51.32 (+0.26), DIA: 168.95 (+1.26), IBB: 307.79 (+5.88), AMGN: 148.05 (+6.83), TWTR: 29.83 (+2.21), CELG: 116.98 (+4.79)

Let's Run Down the Bear-Market Checklist
at The Street - Wed Sep 30, 3:00PM CDT
Continued bull run would need investors to be more comfortable with risk.
SBUX: 58.78 (+0.09), SOCL: 18.50 (+0.17), XLB: 43.56 (+0.57), HD: 119.65 (+0.97), NKE: 122.10 (-1.09), XLY: 76.69 (+0.26), IBB: 307.79 (+5.88), DIS: 103.39 (-0.38), XLE: 68.09 (+0.85)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sandvik's Q3 2026: Robust Growth Amid Market Shifts

Updated Category News Views 2

Riding the Uptrend: Sandvik's Stirring Q3 Performance Let's break out the potato chips and dig into Sandvik's third-quarter numbers for 2026. This Stockholm machinery giant isn't just moving metal; it's moving the market needle in ways only a few can manage. You see, Sandvik pulled in an order intake of SEK 36,948 million, which ain't shabby when compared to last year's...

Continue Reading
Sunlife Partners With Rippling to Streamline Benefits

Updated Category News Views 13

Sunlife Enters the Tech Game It ain't your granddaddy's insurance world no more. Sunlife U.S. is hopping on the tech bandwagon, joining Rippling's Preferred Carrier Program to make employee benefits slicker and faster. This isn't just about insurance paperwork; it's about reshaping how businesses handle their payroll, IT, and HR under one digital roof. Why it Matters for...

Continue Reading
Parents Miss Key Steps to Combat Childhood Myopia

Updated Category News Views 3

A Growing Concern in Children's Vision Let’s face it, parents are grappling with a lot these days, and one area where they're playing catch up is in understanding childhood myopia. A recent AAV survey sheds some light on this and reveals that while parents may grasp the future risks of nearsightedness, they're stumbling over what simple steps today could stave off...

Continue Reading
Flood Insurance: Crucial for Silver Spring Owners?

Updated Category News Views 5

Flood Risk: A Reality Check for Homeowners Alright folks, let's dive into a topic that's been soaking up attention lately—flood insurance in Silver Spring, Maryland. Seems like everyone assumes they're safe from watery doom if they're standing outside those high-risk FEMA flood zones. But here's the kicker: Glenda Martinez, the big cheese at Xcella Insurance Group,...

Continue Reading
Local Visibility Crisis Looms for Small Businesses

Updated Category News Views 3

Scrolling through these fresh stats from BrightLocal's recent report, you can almost hear the alarm bells echoing across small towns and city squares. The data paints a surprisingly sobering picture: despite the fact that 71% of folks are heading straight to Google to find local businesses, only a mere 22% of small business owners are tagging it as one of their top tools...

Continue Reading
Dr. Anke Otto-Wolf's BEFORE Framework Revolutionizes SEL

Updated Category News Views 1

Teaching Kids to Catch Themselves: Introducing BEFORE Calling October Bullying Prevention Month seems quaint when you consider how often kids get shoved around, physically or emotionally. What’s surprising is how one simple word, ‘BEFORE,’ might just be the game-changer. Dr. Anke Otto-Wolf is betting big on it by unveiling the BEFORE Framework™. Imagine kids...

Continue Reading
Indegene Gains Accolades for AI-Driven Pharma Success

Updated Category News Views 0

Indegene's AI Revolution in Pharma There's a new player making noise on the pharma playground, and it's called Indegene. This company just snagged the 2026 Global Enabling Technology Leadership Recognition from Frost & Sullivan for shaking up pharmaceutical commercialization with its cutting-edge AI arsenal. No fluff here—just a straight dive into how they're turning...

Continue Reading
Frost & Sullivan Boosts China Insight with LeadLeo

Updated Category News Views 3

Navigating China's Complex Market Landscape You've got to understand, the stakes in China are like a high-wire act—mystifying and risky, yet bountiful if you play your cards right. Frost & Sullivan's latest maneuver into China's business intel scene is basically the lifeline for navigating this increasingly convoluted market. With China surging ahead in AI, biotech, and...

Continue Reading
Littleton U-Pull-It Kicks off New Era with a Bang

Updated Category News Views 2

A Fresh Chapter for Littleton U-Pull-It There's nothing quite like the thrill of a new beginning, especially when it promises to shake up the local business scene. Littleton U-Pull-It, under new ownership, seems to be gearing up for exactly that. They're setting the stage with a grand opening event on October 24. When old hands in the business world like me see moves like...

Continue Reading
Millrose Faces Class Action: Blame Game in Motion

Updated Category News Views 10

Millrose Properties: A Realty Ruckus Unfolding Sometimes, in the world of stocks, it feels like you're two steps ahead of the scam or already knee-deep in trouble. Millrose Properties, Inc. struck a rather sour chord recently with an 8.53% stock drop, leaving investors feeling the burn. Here's the juice: a securities fraud class action is in motion, and if you're holding...

Continue Reading

Top 5 Most Recently Viewed Articles

NEXA Unlimited: Disrupting Mortgage Broker Earnings

Updated Category News Views 26

What Exactly Is NEXA Unlimited? In a game-changer twist, NEXA Lending has launched something that could dramatically shuffle the current mortgage broker model deck. Dubbed NEXA Unlimited, this new model promises no less than 100% revenue access to its loan officers. We're talking zero fees—flat, funding, closing—none of ‘em. This isn't a small tweak or a cosmetic...

Continue Reading
Uncovering Accounting Issues at Super Micro Computer: A Deep Dive

Updated Category News Views 112

Investigation of Super Micro Computer, Inc. (NASDAQ: SMCI) Recent developments have brought significant attention to the investigation concerning Super Micro Computer, Inc. The law firm Bronstein, Gewirtz & Grossman, LLC is actively looking into potential claims for shareholders who have acquired securities from Super Micro, aiming to uncover details related to alleged...

Continue Reading
Nadia Partners Launches Innovative AI Data Centers in Canada

Updated Category News Views 1385

Nadia Partners Unveils Beacon AI Centers In a groundbreaking move, Nadia Partners has announced the launch of Beacon AI Centers, a forward-thinking data center development company. This initiative marks a significant transition for the company as it emerges from stealth mode to redefine the landscape of data center operations to cater to the increasing needs of artificial...

Continue Reading
BioLab Holdings, Inc. Partners in Cold Atmospheric Plasma Innovation

Updated Category News Views 169

Exciting Collaboration in Medical Technology BioLab Holdings, Inc., a renowned player in the medical manufacturing sector, is thrilled to unveil a groundbreaking partnership. This collaboration with terraplasma medical GmbH promises to revolutionize portable antimicrobial solutions in the realm of wound care and dermatology. Both companies are committed to enhancing...

Continue Reading
Investors Stand Up Against Sage Therapeutics' Alleged Deceptions

Updated Category News Views 48

Legal Action Against Sage Therapeutics Recent news has emerged as investors seek justice against Sage Therapeutics, Inc., a company traded on NASDAQ under the ticker SAGE. Currently, it is facing a securities class action lawsuit led by Levi & Korsinsky, LLP, a firm known for advocating for the rights of investors impacted by potential misconduct. Understanding the Class...

Continue Reading